期刊文献+

藏族人群乙型肝炎疫苗免疫应答

The immune response of hepatitis B vaccine in Tibetan nationality
原文传递
导出
摘要 目的考核酵母基因工程乙肝疫苗在易感藏族人群中的免疫原性。方法为1 609名从横断面调查中筛选出的HBV易感者接种汉逊酵母乙型肝炎疫苗,剂量10ug/mL,程序0、1、6个月。免疫7个月后,随机整群选择615名接种者采集静脉血标本,固相放射免疫(RIA)法定性检测HBsAg、抗-HB,Abbott公司的MEIA试剂定量检测抗-HBs。结果共549名接种者抗-HBs阳转,阳转率89.3%,抗-HBs阳转者几何平均浓度(GMC)为3 514.6mIU/mL;抗体阳转率和GMC均呈随年龄降低的趋势,而与接种者的性别、职业、居住地等无关;观察结束时检出8名HBsAg阳转者,其原因待查。结论藏族人群对基因工程乙肝疫苗有良好的免疫应答。 Objective To observe the immunogenicity of YDV ( Yeast - derived hepatitis E. vaccine) among susceptible Tibetan population. Method 1 609 HBV susceptibles were selected by cross- sectional survey, which were inoculated with YDV of 10μg/ml at the 0, 1 st and 6th month. After 7 months of immane, random- ly selected 615 venous blood samples. HBsAg and anti -HB were qualitative detectior by RIA, and anti - HBs was quantitative detection by MEIA reagent which produced by Abbott company. Results It was shown that 549 inoculators'anti - HBs were seroconversion, the seroconversion rate was 89.3%, and the geometric mean concentration (GMC) of anti - HBs seroconversion was 3 514. 6mIU/mL. Both antibody seroconversion rate and GMC were decreased with the age increased, and they had no relation with gender, occupations, hab- itations of inoculators. At the end of observation, there were 8 cases of HBsAg positive,, which need further investigation. Condusions Tibetan nationality crowds have a good immune response to Yeast - derived hepatitis B vaccine.
出处 《医学动物防制》 2012年第7期775-777,共3页 Journal of Medical Pest Control
关键词 藏族人群 乙肝疫苗 接种率 免疫应答 Tibetan nationality Hepatitis B vaccine Inoculation rate Immune response
  • 相关文献

参考文献11

  • 1易虎 李永盛 唐志坚等.青海省同德县病毒性肝炎感染状况调查.中国公共卫生,2005,21:33-35.
  • 2Ghendon Y.WHO strategy for the global elimination of new cases ofhepatitis B[J].Vaccine,1990,8(Suppl):129-133.
  • 3World Health Organization.Report of the Fourteenth Meeting of theGlobal Advisory Group of the Expanded Programme on Immunization[J].Wkly Epidemiol Rcc,1992,3:11-15.
  • 4刘寿鹏 樊启声 李惠等.青海省441例乙型肝炎疫苗免疫效果考核.青海医药杂志,1988,10(3):10-11.
  • 5Whittle HC,Inskip H,How AJ,et al.Vaccination against hepatitis Band protection against chronic viral carriage in the Gambia[J].Lan-cet,1991,337(8 744):747-750.
  • 6Hsu NHM,Chen DS,Chuang CH,et al.Efficacy of a mass hepatitisB vaccination program in Taiwan:studies on 3 464 infants of hepatitisB virus surface antigen-carrier mothers[J].JAMA,1988,260:2231-2 235.
  • 7Boxall EH,Sira JA,El-Shuhkri N,et al.Long-term persistence ofimmunity to hepatitis B after vaccination during infancy in a countrywhere endemicity is low[J].JID,2004,190(1):1 264-1 269.
  • 8Kojouharova M,Teoharov P,Bahtchevanova T,et al.Safety and im-munogenicity of a yeast-derived recombinant hepatitis B vaccine inBulgarian newborns[J].Infection,2001,29(6):342-344.
  • 9颜天强,李浩,陈大保,罗述斌,陶运宏,王建坤,张旭,张佩,王继杰,周加民,曹惠霖.HBsAg阴性母亲的新生儿乙型肝炎疫苗免疫后抗-HBs的动态研究[J].病毒学报,1991,7(A12):61-63. 被引量:3
  • 10谢永富,张勇,邢占春,马景臣,赵卉云,邓贵林,马辛未,陈素良,郭锁贤,曹惠霖,孙永德.农村新生儿出生后3个月内开始接种三剂10μg乙型肝炎血源疫苗的免疫效果[J].病毒学报,1991,7(A12):77-80. 被引量:11

二级参考文献11

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部